Brief: Applied Molecular Transport Reports Second Quarter 2020 Financial Results
11/08/2020 21:12
Aug 11 (Reuters) - Applied Molecular Transport Inc.
AMTI.O :
* APPLIED MOLECULAR TRANSPORT REPORTS SECOND QUARTER 2020
FINANCIAL RESULTS
* APPLIED MOLECULAR . - PLANS TO INITIATE 3 PHASE 2 CLINICAL
TRIALS FOR AMT-101 IN 2020; ANTICIPATES TOP-LINE DATA READOUTS
IN 2H 2021 AND 1H 2022
* APPLIED MOLECULAR TRANSPORT INC. - QTRLY NET LOSS $15.4
MILLION
VERSUS $7.3 MILLION
Source text for Eikon: ID:nGNX75LfMR
Further company coverage: AMTI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Applied Molecular Transport.
See all newsApplied Molecular Transport Inc. expected to post a loss of 50 cents a share - Earnings Preview
Brief: Applied Molecular Transport Inc. - On Oct 23 Got Written Notice Nasdaq Had Granted Co's Request For Continued Listing On Nasdaq
U.S. STOCKS ON THE MOVE-Boston Scientific, Rockwell Medical, Visa
U.S. STOCKS ON THE MOVE-Fox Corp, Cisco Systems, Darden Restaurants
Applied Molecular rises on merger deal with Cyclo Therapeutics